Skip to main content

Zimmer Hip Implant Lawsuit Dismissed Over Late Filing

Zimmer Hip Implant Lawsuit Dismissed Over Late Filing

Zimmer Hip Implant Lawsuit Dismissed Over Late Filing

Introduction

U.S. District Judge Edward G. Smith dismissed a plaintiff's claims over defective Zimmer prosthetic hip implant stating she failed to file the case within the two-year statute of limitations.

The plaintiff underwent total hip surgery in 2011 when she was implanted with Zimmer M/L Taper Kinectiv Stem and Neck (the “Kinectiv”) with a Versys Femoral Head (the “Versys Head”), collectively referred to as Zimmer Device. She eventually got it removed in 2015 after experiencing metallosis, which is an adverse local tissue reaction allegedly due to the implant. She filed a lawsuit in February 2017 against the hip implant maker. The Pennsylvania jury stated that she was late by just a few days in filing the case.

Zimmer lawsuits filed across the U.S. claim that the Zimmer M/L Taper Hip Prosthesis and Zimmer VerSys Hip femoral head are defectively designed,  pose major health risks when paired together, and have a tendency to corrode and leave metal pieces inside the body often needing the device to be removed.

Zimmer Durom Hip Cup lawsuits were centralized on June 9, 2010, in the U.S District of New Jersey before Judge Susan D. Wigenton as multidistrict litigation, MDL No. 2158 (In Re: Zimmer Durom Hip Cup Products Liability Litigation).

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.